Neuvian Skincare Granted Breakthrough U.S. Patent for Dual Peptide Skin Technology

First-to-market stabilization of L-Carnosine + GHK-Cu introduces next-generation visible skin rejuvenation.

MIAMI, Sept. 9, 2025 /PRNewswire/ -- Neuvian Skincare, the beauty-tech innovator, announced today that it has been granted U.S. Patent No. 12,377,156 B2, titled "Compositions and Methods for Treatment of Wounds and Inflammatory Skin Conditions." The patent includes granted composition and method claims covering Neuvian's dual-peptide formulation for inflammatory skin conditions, including wounds, scars, and eczema, reinforcing the company's leadership in dermatology.

This milestone protects Neuvian's Bioidentical Dual Peptide Technology™, the first cyclodextrin-stabilized complex of L-Carnosine and GHK-Cu. This breakthrough secures composition-level protection for their combined use—a global first in peptide-based skincare. The patent positions Neuvian as a pioneer in beauty science with a platform for consumer products and potential clinical applications.

"This achievement validates our scientific approach to peptide innovation," said Jacob Miguel, CEO and Founder of Neuvian Skincare. "By creating our Bioidentical Dual Peptide Technology™, we are advancing a new class of skincare solutions designed to work in synergy with the skin's natural processes, providing benefits not previously possible. At Neuvian, every product is more than a launch—it's part of building the foundation for what's next."

Why This Matters for Consumers

• Two powerful peptides, one stabilized complex: L-Carnosine helps defend skin from oxidative stress and visible signs of aging, while GHK-Cu supports firmness, elasticity, and natural renewal.
• Unique synergy, new results: These peptides, extensively studied on their own, help amplify visible benefits when paired in Neuvian's patented stabilized form.
• Support at the source: In vitro, non-clinical research showed that the complex influenced markers tied to collagen, elasticity, and barrier function—indicating broad support for skin vitality.

"While L-Carnosine and GHK-Cu have been studied independently, our proprietary approach brings them together for the first time in a stabilized complex," said Spencer Bouhadir, Chief Scientific Officer. "This creates a unique synergy that supports skin function in ways not achieved in conventional skincare."

Science To Skincare: NMF+ Rejuvenation Serum
Translating breakthrough science into daily skincare, the NMF+ Rejuvenation Serum is powered by Neuvian's patented Bioidentical Dual Peptide Technology™.  Suitable for all skin types, including sensitive skin, this serum reflects Neuvian's mission: science-backed, non-invasive, peptide-powered skincare.

"In an industry long overdue for disruption, Neuvian is redefining what's possible in skincare science, merging cosmetic elegance with high-performance results," added Bouhadir.

Global Strategy & Expansion
Leveraging its PCT application, the company is pursuing global expansion, licensing opportunities, and professional skincare markets while strengthening its global IP protection. For more information, please visit neuvian.com 

About Neuvian Skincare:
Founded in 2024 and based in Miami, FL, Neuvian Skincare is a beauty-tech brand applying organic chemistry, biotechnology, and epigenetics to create advanced skincare. The company develops proprietary, patented peptide innovations in-house, designed to complement the skin's natural biology and deliver visible results. All products are developed and manufactured in the United States.

Contact Information:
Samantha Grant - [email protected]
Nicole Akers - [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/neuvian-skincare-granted-breakthrough-us-patent-for-dual-peptide-skin-technology-302550389.html

SOURCE Neuvian Skincare